Major Cause of Drug-resistance in Prostate Cancer Patients Identified

News   Aug 15, 2017 | Original story from Mayo Clinic

 
Major Cause of Drug-resistance in Prostate Cancer Patients Identified

Mutations in the SPOP gene (depicted on the left) can be used to guide administration of anti-cancer drugs (labeled treatment A through D below) in patients with prostate cancer. Credit: Mayo Clinic

 
 
 

RELATED ARTICLES

Duplicate Genes Offer a Explanation for Differences Between the Sexes

News

A study in flies has identified the process by duplicating a gene can help resolve genetic sexual conflict.

READ MORE

Pre-Clinical Safety in Cancer Drug Development: “Attitude to Safety Needs to Change”

News

Many companies involved in cancer drug research and development need to re-think their use of safety data in helping to bring new drugs to cancer patients.

Dr Richard Knight of ApconiX will tell this month’s conference, that greater focus on pre-clinical safety should be fundamental to the development of new cancer therapies.

READ MORE

How Proteins Shape-Shift By the Hour is Central to Figuring Out How Circadian Clocks Work

News

Scientists utilising X-ray crystallography and NMR spectroscopy have discovered that the way proteins move hour by hour is central to cyanobacteria's circadian clock function.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE